HIV-1 Reservoirs During Suppressive Therapy
- PMID: 26875617
- PMCID: PMC5319871
- DOI: 10.1016/j.tim.2016.01.006
HIV-1 Reservoirs During Suppressive Therapy
Abstract
The introduction of antiretroviral therapy (ART) 20 years ago has dramatically reduced morbidity and mortality associated with HIV-1. Initially there was hope that ART would be curative, but it quickly became clear that even though ART was able to restore CD4(+) T cell counts and suppress viral loads below levels of detection, discontinuation of treatment resulted in a rapid rebound of infection. This is due to persistence of a small reservoir of latently infected cells with a long half-life, which necessitates life-long ART. Over the past few years, significant progress has been made in defining and characterizing the latent reservoir of HIV-1, and here we review how understanding the latent reservoir during suppressive therapy will lead to significant advances in curative approaches for HIV-1.
Keywords: HIV-1; HIV-1 reservoirs; latent HIV-1; long-term ART; memory CD4(+) T cells; persistent HIV-1.
Copyright © 2016 Elsevier Ltd. All rights reserved.
Figures
References
-
- Hutter G, et al. Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantation. N Engl J Med. 2009;360:692–698. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous
